Trial results for 'Electronic Proactive Outreach for Smokers With COPD' were posted on ClinicalTrials.gov on 2025-07-03, involving 124 participants with COPD.
Background
Chronic obstructive pulmonary disease (COPD) is a common respiratory disease, with 90% of cases directly linked to smoking. Many patients with COPD continue to smoke, highlighting an urgent need for effective cessation support. Proactive tobacco treatment programs aim to identify patients outside of routine clinical appointments and engage them in supported quit attempts. Historically, these programs have often relied on telephone outreach, which can be resource-intensive. The exploration of electronic methods, such as texting and secure messaging, offers a potentially less resource-intensive yet effective alternative for delivering tobacco cessation interventions.
Trial design
This completed study, designated as Phase NA, enrolled 124 participants diagnosed with Pulmonary Disease, Chronic Obstructive and Smoking. The trial compared a 'Proactive Outreach' group, utilizing electronic methods like texting and secure messaging for tobacco treatment, against a 'Usual Care' group. The study aimed to evaluate the effectiveness of electronic proactive outreach in engaging smokers with COPD in cessation efforts.
Key results
The trial reported key measurements comparing the Proactive Outreach group to Usual Care:
- Participation in Tobacco Cessation Treatment:
- Usual Care: 9 Participants
- Proactive Outreach: 29 Participants
- 30-Day Abstinence:
- Usual Care: 2 Participants
- Proactive Outreach: 6 Participants
- Quit or Cut Down:
- Usual Care: 12 Participants
- Proactive Outreach: 32 Participants
- 7-day Abstinence:
- Usual Care: 3 Participants
- Proactive Outreach: 8 Participants
- Moved Upward on the Quit Ladder:
- Usual Care: 13 Participants
- Proactive Outreach: 23 Participants
- Cut Down in Heaviness of Smoking:
- Usual Care: 9 Participants
- Proactive Outreach: 25 Participants
What this means
The results indicate that electronic proactive outreach significantly increased participation in tobacco cessation treatment among smokers with COPD, with 29 participants in the proactive outreach group engaging in treatment compared to 9 in usual care. Furthermore, the proactive outreach group showed higher rates across various cessation metrics, including 30-day abstinence (6 vs 2 participants), 7-day abstinence (8 vs 3 participants), and those who quit or cut down (32 vs 12 participants). These findings suggest that electronic methods could be an effective and potentially more efficient strategy to support smoking cessation in this vulnerable patient population, offering a scalable alternative to traditional, resource-intensive approaches.
Source
The information for these trial results was obtained from ClinicalTrials.gov, a public database of clinical studies. The results for the study 'Electronic Proactive Outreach for Smokers With COPD' were posted on 2025-07-03 on clinicaltrials.gov.
